Skip to menu Skip to content Skip to footer
Dr Chris McMillan
Dr

Chris McMillan

Email: 
Phone: 
+61 7 336 54629

Overview

Background

Dr Chris McMillan is a virologist and vaccinologist whose work focuses on innovative vaccine platforms and advanced delivery technologies. His research spans several pathogens of global health importance, including seasonal and pandemic influenza, flaviviruses, poliovirus, SARS-CoV-2, and emerging viral threats. He works across multiple vaccine modalities, from recombinant proteins and virus-like particles to DNA, mRNA, and self-amplifying RNA platforms.

A major research focus is improving vaccine performance through targeted skin delivery using microarray patches (MAPs) to access immune-rich epidermal and dermal layers. By applying spatial transcriptomics and other tissue-scale profiling tools, we aim to map how MAP vaccines interact with the skin and draining lymph nodes in vivo to inform next-generation vaccine design.

He is also focusing on new RNA technologies, including self-amplifying RNA systems for both vaccine and therapeutic applications. This work integrates virology, RNA engineering, and spatial immunology to better understand and enhance immune responses at the tissue level.

Availability

Dr Chris McMillan is:
Available for supervision

Qualifications

  • Bachelor of Science, The University of Queensland
  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Chris McMillan’s works on UQ eSpace

33 works between 2019 and 2025

21 - 33 of 33 works

2021

Journal Article

Developing a stabilizing formulation of a live chimeric dengue virus vaccine dry coated on a high-density microarray patch

Choo, Jovin J. Y., McMillan, Christopher L. D., Fernando, Germain J. P., Hall, Roy A., Young, Paul R., Hobson-Peters, Jody and Muller, David A. (2021). Developing a stabilizing formulation of a live chimeric dengue virus vaccine dry coated on a high-density microarray patch. Vaccines, 9 (11) 1301, 1301. doi: 10.3390/vaccines9111301

Developing a stabilizing formulation of a live chimeric dengue virus vaccine dry coated on a high-density microarray patch

2021

Journal Article

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

McMillan, Christopher L. D., Cheung, Stacey T. M., Modhiran, Naphak, Barnes, James, Amarilla, Alberto A., Bielefeldt-Ohmann, Helle, Lee, Leo Yi Yang, Guilfoyle, Kate, van Amerongen, Geert, Stittelaar, Koert, Jakob, Virginie, Lebas, Celia, Reading, Patrick, Short, Kirsty R., Young, Paul R., Watterson, Daniel and Chappell, Keith J. (2021). Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses. npj Vaccines, 6 (1) 135, 135. doi: 10.1038/s41541-021-00395-4

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

2021

Journal Article

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine

McMillan, Christopher L. D., Choo, Jovin J. Y., Idris, Adi, Supramaniam, Aroon, Modhiran, Naphak, Amarilla, Alberto A., Isaacs, Ariel, Cheung, Stacey T. M., Liang, Benjamin, Bielefeldt-Ohmann, Helle, Azuar, Armira, Acharya, Dhruba, Kelly, Gabrielle, Fernando, Germain J. P., Landsberg, Michael J., Khromykh, Alexander A., Watterson, Daniel, Young, Paul R., McMillan, Nigel A. J. and Muller, David A. (2021). Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine. Science Advances, 7 (44) eabj8065, eabj8065. doi: 10.1126/sciadv.abj8065

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine

2021

Journal Article

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

Amarilla, Alberto A., Sng, Julian D. J., Parry, Rhys, Deerain, Joshua M., Potter, James R., Setoh, Yin Xiang, Rawle, Daniel J., Le, Thuy T., Modhiran, Naphak, Wang, Xiaohui, Peng, Nias Y. G., Torres, Francisco J., Pyke, Alyssa, Harrison, Jessica J., Freney, Morgan E., Liang, Benjamin, McMillan, Christopher L. D., Cheung, Stacey T. M., Guevara, Darwin J Da Costa, Hardy, Joshua M., Bettington, Mark, Muller, David A., Coulibaly, Fasséli, Moore, Frederick, Hall, Roy A., Young, Paul R., Mackenzie, Jason M., Hobson-Peters, Jody, Suhrbier, Andreas ... Khromykh, Alexander A. (2021). A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nature Communications, 12 (1) 3431, 3431. doi: 10.1038/s41467-021-23779-5

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

2021

Journal Article

A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice

Choo, Jovin J. Y., Vet, Laura J., McMillan, Christopher L. D., Harrison, Jessica J., Scott, Connor A. P., Depelsenaire, Alexandra C. I., Fernando, Germain J. P., Watterson, Daniel, Hall, Roy A., Young, Paul R., Hobson-Peters, Jody and Muller, David A. (2021). A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice. npj Vaccines, 6 (1) 66, 66. doi: 10.1038/s41541-021-00328-1

A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice

2021

Journal Article

Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2

Watterson, Daniel, Wijesundara, Danushka K., Modhiran, Naphak, Mordant, Francesca L., Li, Zheyi, Avumegah, Michael S., McMillan, Christopher L. D., Lackenby, Julia, Guilfoyle, Kate, van Amerongen, Geert, Stittelaar, Koert, Cheung, Stacey T. M., Bibby, Summa, Daleris, Mallory, Hoger, Kym, Gillard, Marianne, Radunz, Eve, Jones, Martina L., Hughes, Karen, Hughes, Ben, Goh, Justin, Edwards, David, Scoble, Judith, Pearce, Lesley, Kowalczyk, Lukasz, Phan, Tram, La, Mylinh, Lu, Louis, Pham, Tam ... Chappell, Keith J. (2021). Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clinical & Translational Immunology, 10 (4) e1269, e1269. doi: 10.1002/cti2.1269

Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2

2021

Journal Article

An optimized high-throughput immuno-plaque assay for SARS-CoV-2

Amarilla, Alberto A., Modhiran, Naphak, Setoh, Yin Xiang, Peng, Nias Y. G., Sng, Julian D. J., Liang, Benjamin, McMillan, Christopher L. D., Freney, Morgan E, Cheung, Stacey T. M., Chappell, Keith J., Khromykh, Alexander A., Young, Paul R. and Watterson, Daniel (2021). An optimized high-throughput immuno-plaque assay for SARS-CoV-2. Frontiers in Microbiology, 12 625136, 625136. doi: 10.3389/fmicb.2021.625136

An optimized high-throughput immuno-plaque assay for SARS-CoV-2

2021

Journal Article

Adjuvant selection for influenza and RSV prefusion subunit vaccines

Isaacs, Ariel, Li, Zheyi, Cheung, Stacey T. M., Wijesundara, Danushka K., McMillan, Christopher L. D., Modhiran, Naphak, Young, Paul R., Ranasinghe, Charani, Watterson, Daniel and Chappell, Keith J. (2021). Adjuvant selection for influenza and RSV prefusion subunit vaccines. Vaccines, 9 (2) 71, 1-14. doi: 10.3390/vaccines9020071

Adjuvant selection for influenza and RSV prefusion subunit vaccines

2021

Journal Article

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Idris, Adi, Davis, Alicia, Supramaniam, Aroon, Acharya, Dhruba, Kelly, Gabrielle, Tayyar, Yaman, West, Nic, Zhang, Ping, McMillan, Christopher L.D., Soemardy, Citradewi, Ray, Roslyn, O'Meally, Denis, Scott, Tristan A., McMillan, Nigel A.J. and Morris, Kevin V. (2021). A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19. Molecular Therapy, 29 (7), 2219-2226. doi: 10.1016/j.ymthe.2021.05.004

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

2021

Journal Article

The next generation of influenza vaccines: towards a universal solution

McMillan, Christopher L. D., Young, Paul R., Watterson, Daniel and Chappell, Keith J. (2021). The next generation of influenza vaccines: towards a universal solution. Vaccines, 9 (1) 26, 1-20. doi: 10.3390/vaccines9010026

The next generation of influenza vaccines: towards a universal solution

2020

Journal Article

A novel purification procedure for active recombinant human DPP4 and the inability of DPP4 to bind SARS-CoV-2

Xi, Cecy R., Di Fazio, Arianna, Nadvi, Naveed Ahmed, Patel, Karishma, Xiang, Michelle Sui Wen, Zhang, Hui Emma, Deshpande, Chandrika, Low, Jason K K, Wang, Xiaonan Trixie, Chen, Yiqian, McMillan, Christopher L. D., Isaacs, Ariel, Osborne, Brenna, Vieira de Ribeiro, Ana Júlia, McCaughan, Geoffrey W., Mackay, Joel P., Church, W Bret and Gorrell, Mark D. (2020). A novel purification procedure for active recombinant human DPP4 and the inability of DPP4 to bind SARS-CoV-2. Molecules , 25 (22) 5392, 1-16. doi: 10.3390/molecules25225392

A novel purification procedure for active recombinant human DPP4 and the inability of DPP4 to bind SARS-CoV-2

2019

Other Outputs

Rational design of a recombinant subunit influenza vaccine

McMillan, Christopher (2019). Rational design of a recombinant subunit influenza vaccine. PhD Thesis, School of Chemistry and Molecular Biosciences, The University of Queensland. doi: 10.14264/uql.2019.923

Rational design of a recombinant subunit influenza vaccine

2019

Journal Article

Basimarols A, B, and C, Highly Oxygenated Pimarane Diterpenoids from Basilicum polystachyon

Tan, Yuen P., Xue, Yongbo, Savchenko, Andrei I., Houston, Sevan D., Modhiran, Naphak, McMillan, Christopher L. D., Boyle, Glen M., Bernhardt, Paul V., Young, Paul R., Watterson, Daniel and Williams, Craig M. (2019). Basimarols A, B, and C, Highly Oxygenated Pimarane Diterpenoids from Basilicum polystachyon. Journal of Natural Products, 82 (10) acs.jnatprod.9b00522, 2828-2834. doi: 10.1021/acs.jnatprod.9b00522

Basimarols A, B, and C, Highly Oxygenated Pimarane Diterpenoids from Basilicum polystachyon

Funding

Current funding

  • 2023 - 2025
    Broad-spectrum vaccine design for flaviviruses and henipaviruses
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2022 - 2026
    Evaluation of a breast cancer DNA vaccine
    UniQuest Pty Ltd
    Open grant

Past funding

  • 2023 - 2025
    Development of monovalent type 1 and trivalent poliovirus VLP patches
    Global Polio Eradication Initiative
    Open grant
  • 2022 - 2025
    Enhancing pandemic preparedness through nucleic acid Nanopatch skin vaccination
    Advance Queensland Industry Research Fellowships
    Open grant

Supervision

Availability

Dr Chris McMillan is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Chris McMillan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au